MARKET

LSAQ

LSAQ

Lifesci Acquisition II Corp.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.87
-0.10
-1.02%
Opening 12:27 07/23 EDT
OPEN
9.93
PREV CLOSE
9.97
HIGH
9.94
LOW
9.87
VOLUME
939
TURNOVER
--
52 WEEK HIGH
12.68
52 WEEK LOW
9.78
MARKET CAP
92.52M
P/E (TTM)
-98685.0000
1D
5D
1M
3M
1Y
5Y
Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B
 
Benzinga · 05/11 18:46
'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines
Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here is a look back at the week in SPACs for deals, rumors and headline news all covered on Benzinga’s “SPACs Attack.”
Benzinga · 05/11 18:27
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of LifeSci Acquisition II Corp. (Nasdaq – LSAQ)
BALA CYNWYD, PA / ACCESSWIRE / May 7, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of LifeSci Acquisition II Corp. ("LifeSci II" or the "Company") (Nasdaq:LSAQ) for possible breaches of fid...
ACCESSWIRE · 05/07 22:23
LifeSci Acquisition Corp. pops 4.5% on SPAC deal to take Science 37 public at $1.1B valuation
LifeSci Acquisition II Corp. (LSAQ) popped nearly 5% Friday after announcing plans to take drug-trials platform Science 37 public through a SPAC deal that values the firm at about $1.1B.LSAQ’s
Seekingalpha · 05/07 14:29
BRIEF-Science 37 To Become Publicly Listed Via Merger With LifeSci Acquisition II Corp
reuters.com · 05/07 11:59
Science 37 To Go Public Through Merger With LifeSci Acquisition II Corp.; Transaction Values Science 37 At Enterprise Value Of $1.05B
Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial
Benzinga · 05/07 11:56
10-Q: LIFESCI ACQUISITION II CORP.
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS References in this report (the...
Edgar Online - (EDG = 10Q, 10K) · 02/02 21:08
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LSAQ. Analyze the recent business situations of Lifesci Acquisition II Corp. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About LSAQ
LifeSci Acquisition II Corp. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus on businesses that have their primary operations located in North America in the healthcare industry.

Webull offers kinds of Lifesci Acquisition II Corp stock information, including NASDAQ:LSAQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LSAQ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LSAQ stock methods without spending real money on the virtual paper trading platform.